Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Impact of Whole-Body Vibration and Relaxation Techniques on Adolescent Athlete Girls With Triad Syndrome" (WBV for triad)

8 maj 2026 uppdaterad av: shaimaa Mohamed hamed, MTI University

This study aims to explore the effects of Whole-Body Vibration (WBV) exercises and relaxation techniques on adolescent female athletes who are experiencing Female Athlete Triad Syndrome - a condition that may include low bone density, irregular menstrual cycles, and low energy availability.

Participants will take part in a structured program combining vibration training and relaxation sessions over several weeks. The goal is to determine whether this combination can improve bone health, menstrual regularity, physical performance, and overall well-being in young female athletes.

Studieöversikt

Detaljerad beskrivning

The Female Athlete Triad is a medical condition commonly observed in adolescent female athletes and is characterized by three interrelated components: low energy availability (with or without an eating disorder), menstrual dysfunction, and decreased bone mineral density. These factors can negatively affect growth, performance, and long-term health.

This randomized controlled study aims to investigate the combined effects of Whole-Body Vibration (WBV) training and relaxation techniques on adolescent athlete girls diagnosed with the Female Athlete Triad Syndrome.

Participants will be divided into two groups : study group will receive WBV and relaxation training and control group will receive relaxation technique only. The intervention will be conducted for 8 weeks under the supervision of a physiotherapist.

Primary outcomes will include changes in bone mineral density and hormonal regulation. Secondary outcomes will assess psychological well-being.

This study seeks to provide evidence on the potential benefits of combining WBV and relaxation techniques to support bone health, hormonal regulation, and physical and mental recovery among adolescent female athletes.

Studietyp

Interventionell

Inskrivning (Beräknad)

50

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Low energy availability (with or without disordered eating)
  • Menstrual dysfunction (oligomenorrhea)
  • Low bone mineral density or a history of stress fractures

Exclusion criteria:

  • Recent fractures or unhealed stress fractures within the last 6 months.
  • Presence of serious medical conditions that contraindicate WBV or exercise participation, such as: Uncontrolled cardiovascular disease, Uncontrolled hypertension, Neurological disorders, Severe vestibular disorders, Active cancer, Bleeding/clotting disorders.
  • Severe eating disorder requiring inpatient medical or psychiatric treatment.
  • Current use of medications that significantly affect bone or hormonal status
  • Participation in another interventional clinical study within the last 3 months.
  • Inability or unwillingness to provide assent/consent or comply with study procedures.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Whole body vibration
group A contains 25 Participants in this group will receive Whole-Body Vibration (WBV) combined with Relaxation training three times per week for 8 weeks. Each session will include static and dynamic exercises performed on a vibration platform under physiotherapist supervision. The intervention aims to improve bone mineral density and hormonal regulation in adolescent athlete girls with Female Athlete Triad Syndrome.

Participants in study group will receive a combination of Whole-Body Vibration (WBV) training and relaxation techniques during the same intervention period.

Each session will include approximately 15-20 minutes of WBV exercises performed on a vibration platform under physiotherapist supervision, followed by 20-30 minutes of guided relaxation training involving deep breathing, progressive muscle relaxation, and mindfulness-based relaxation.

The sessions will be conducted three times per week for 8 weeks. In control group participant will receive relaxation techniques the program will include a combination of guided breathing exercises, progressive muscle relaxation, and mindfulness-based relaxation.Each session will last about 20-30 minutes, conducted three times per week for 8 weeks, supervised by a physiotherapist or psychologist trained in relaxation therapy.

for both groups (A&B) will receive relaxation Techniques Training

The program may include:

  1. Diaphragmatic (Deep) Breathing Focus on slow, controlled breathing from the diaphragm Typically: 4-6 breaths per minute
  2. Progressive Muscle Relaxation (PMR) Tensing and relaxing different muscle groups Increases body awareness and reduces physical tension
  3. Autogenic Training Uses visualizations and self-suggestions to induce relaxation (e.g., "My arms feel heavy and warm") Enhances self-regulation and calmness
  4. Mindfulness Meditation Focuses on present-moment awareness Helps reduce intrusive thoughts, improve attention and emotional regulation
Experimentell: Relaxation training
group B contain 25 Participants will receive guided relaxation training three times per week for 8 weeks. Each session will include deep breathing exercises, progressive muscle relaxation, and mindfulness-based relaxation, supervised by a physiotherapist.

for both groups (A&B) will receive relaxation Techniques Training

The program may include:

  1. Diaphragmatic (Deep) Breathing Focus on slow, controlled breathing from the diaphragm Typically: 4-6 breaths per minute
  2. Progressive Muscle Relaxation (PMR) Tensing and relaxing different muscle groups Increases body awareness and reduces physical tension
  3. Autogenic Training Uses visualizations and self-suggestions to induce relaxation (e.g., "My arms feel heavy and warm") Enhances self-regulation and calmness
  4. Mindfulness Meditation Focuses on present-moment awareness Helps reduce intrusive thoughts, improve attention and emotional regulation

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
hormonal regularity
Tidsram: 2 months
hormonal regularity via Estrogen serum analysis It involves measuring the levels of estrogens (primarily estradiol) in the blood to evaluate reproductive health, menstrual cycle function, fertility, menopause status, or hormonal disorders.
2 months
bone mineral density
Tidsram: 2 months
bone mineral density via DEXA. that used to diagnose osteoporosis, assess fracture risk, and monitor changes in bone over time. The gold standard for assessing BMD is the DEXA scan (also known as DXA, or Dual-Energy X-ray Absorptiometry).
2 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
psychological well-being
Tidsram: 2 months
psychological well-being via Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959) This scale measures the anxiety symptoms severity. It has 14 items and series of symptoms define every item. 5 point Likert scale is used to rate each item i.e. (1) never, (2) rarely, (3) sometimes, (4) very often, (5) always. Mild anxiety is indicated by lowest score and the highest scores indicate severe anxiety.
2 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

2 november 2025

Primärt slutförande (Faktisk)

2 januari 2026

Avslutad studie (Beräknad)

22 maj 2026

Studieregistreringsdatum

Först inskickad

1 maj 2026

Först inskickad som uppfyllde QC-kriterierna

8 maj 2026

Första postat (Faktisk)

14 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

14 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

8 maj 2026

Senast verifierad

1 maj 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera